Jee-Boong Lee1, Chun-Yu Chen1, Bo Liu1, Luke Mugge1, Pornpimon Angkasekwinai2, Valeria Facchinetti3, Chen Dong3, Yong-Jun Liu4, Marc E Rothenberg1, Simon P Hogan1, Fred D Finkelman5, Yui-Hsi Wang6. 1. Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 2. Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Bangkok, Thailand. 3. Department of Immunology, University of Texas and MD Anderson Cancer Center, Houston, Tex. 4. Medimmune, Gaithersburg, Md. 5. Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Medicine, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio; Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, Ohio. 6. Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: yui_hsi.wang@cchmc.org.
Abstract
BACKGROUND: Food-mediated allergic reactions have emerged as a major health problem. The underlying mechanisms that promote uncontrolled type 2 immune responses to dietary allergens in the gastrointestinal tract remain elusive. OBJECTIVE: We investigated whether altering IL-25 signaling enhances or attenuates allergic responses to food allergens. METHODS: Mice of an IL-25 transgenic mouse line (iIL-25Tg mice), which constitutively overexpress intestinal IL-25, and Il17rb(-/-) mice, in which Il17rb gene expression is disrupted, were sensitized and gavage fed with ovalbumin (OVA). We assessed symptomatic characteristics of experimental food allergy, including incidence of diarrhea, incidence of hypothermia, intestinal TH2 immune response, and serum OVA-specific IgE and mast cell protease 1 production. RESULTS: Rapid induction of Il25 expression in the intestinal epithelium preceded onset of the anaphylactic response to ingested OVA antigen. iIL-25Tg mice were more prone and Il17rb(-/-) mice were more resistant to experimental food allergy. Resident intestinal type 2 innate lymphoid cells (ILC2s) were identified as the major producers of IL-5 and IL-13 in response to IL-25. Reconstituting irradiated wild-type mice with Rora(-/-) or Il17rb(-/-) bone marrow resulted in a deficiency or dysfunction of the ILC2 compartment, respectively, and resistance to experimental food allergy. Repeated intragastric antigen challenge induced a significant increase in numbers of CD4(+) TH2 cells, which enhance IL-25-stimulated IL-13 production by ILC2s ex vivo and in vivo. Finally, reconstituted IL-13-deficient ILC2s had reduced capability to promote allergic inflammation, resulting in increased resistance to experimental food allergy. CONCLUSION: IL-25 and CD4(+) TH2 cells induced by ingested antigens enhance ILC2-derived IL-13 production, thereby promoting IgE-mediated experimental food allergy.
BACKGROUND: Food-mediated allergic reactions have emerged as a major health problem. The underlying mechanisms that promote uncontrolled type 2 immune responses to dietary allergens in the gastrointestinal tract remain elusive. OBJECTIVE: We investigated whether altering IL-25 signaling enhances or attenuates allergic responses to food allergens. METHODS:Mice of an IL-25transgenicmouse line (iIL-25Tg mice), which constitutively overexpress intestinal IL-25, and Il17rb(-/-) mice, in which Il17rb gene expression is disrupted, were sensitized and gavage fed with ovalbumin (OVA). We assessed symptomatic characteristics of experimental food allergy, including incidence of diarrhea, incidence of hypothermia, intestinal TH2 immune response, and serum OVA-specific IgE and mast cell protease 1 production. RESULTS: Rapid induction of Il25 expression in the intestinal epithelium preceded onset of the anaphylactic response to ingested OVA antigen. iIL-25Tg mice were more prone and Il17rb(-/-) mice were more resistant to experimental food allergy. Resident intestinal type 2 innate lymphoid cells (ILC2s) were identified as the major producers of IL-5 and IL-13 in response to IL-25. Reconstituting irradiated wild-type mice with Rora(-/-) or Il17rb(-/-) bone marrow resulted in a deficiency or dysfunction of the ILC2 compartment, respectively, and resistance to experimental food allergy. Repeated intragastric antigen challenge induced a significant increase in numbers of CD4(+) TH2 cells, which enhance IL-25-stimulated IL-13 production by ILC2s ex vivo and in vivo. Finally, reconstituted IL-13-deficient ILC2s had reduced capability to promote allergic inflammation, resulting in increased resistance to experimental food allergy. CONCLUSION:IL-25 and CD4(+) TH2 cells induced by ingested antigens enhance ILC2-derived IL-13 production, thereby promoting IgE-mediated experimental food allergy.
Authors: April E Price; Hong-Erh Liang; Brandon M Sullivan; R Lee Reinhardt; Chris J Eisley; David J Erle; Richard M Locksley Journal: Proc Natl Acad Sci U S A Date: 2010-06-07 Impact factor: 11.205
Authors: Aiping Zhao; Joseph F Urban; Rex Sun; Jennifer Stiltz; Motoko Morimoto; Luigi Notari; Kathleen B Madden; Zhonghan Yang; Viktoriya Grinchuk; Thirumalai R Ramalingam; Thomas A Wynn; Terez Shea-Donohue Journal: J Immunol Date: 2010-10-25 Impact factor: 5.422
Authors: D K Chu; Z Mohammed-Ali; R Jiménez-Saiz; T D Walker; S Goncharova; A Llop-Guevara; J Kong; M E Gordon; N G Barra; A E Gillgrass; H Van Seggelen; W I Khan; A A Ashkar; J L Bramson; A A Humbles; R Kolbeck; S Waserman; M Jordana Journal: Mucosal Immunol Date: 2014-04-30 Impact factor: 7.313
Authors: Steven A Saenz; Mark C Siracusa; Jacqueline G Perrigoue; Sean P Spencer; Joseph F Urban; Joel E Tocker; Alison L Budelsky; Melanie A Kleinschek; Robert A Kastelein; Taku Kambayashi; Avinash Bhandoola; David Artis Journal: Nature Date: 2010-03-03 Impact factor: 49.962
Authors: Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie Journal: Nature Date: 2010-03-03 Impact factor: 49.962
Authors: Christopher J Oliphant; You Yi Hwang; Jennifer A Walker; Maryam Salimi; See Heng Wong; James M Brewer; Alexandros Englezakis; Jillian L Barlow; Emily Hams; Seth T Scanlon; Graham S Ogg; Padraic G Fallon; Andrew N J McKenzie Journal: Immunity Date: 2014-07-31 Impact factor: 31.745
Authors: David Chiang; Xintong Chen; Stacie M Jones; Robert A Wood; Scott H Sicherer; A Wesley Burks; Donald Y M Leung; Charuta Agashe; Alexander Grishin; Peter Dawson; Wendy F Davidson; Leah Newman; Robert Sebra; Miriam Merad; Hugh A Sampson; Bojan Losic; M Cecilia Berin Journal: J Allergy Clin Immunol Date: 2018-01-31 Impact factor: 10.793
Authors: Taeko K Noah; Kathryn A Knoop; Keely G McDonald; Jenny K Gustafsson; Lisa Waggoner; Simone Vanoni; Matthew Batie; Kavisha Arora; Anjaparavanda P Naren; Yui-Hsi Wang; Nicholas W Lukacs; Ariel Munitz; Michael A Helmrath; Maxime M Mahe; Rodney D Newberry; Simon P Hogan Journal: J Allergy Clin Immunol Date: 2019-06-05 Impact factor: 10.793
Authors: Michelle T Graham; Sandra Andorf; Jonathan M Spergel; Talal A Chatila; Kari C Nadeau Journal: Curr Allergy Asthma Rep Date: 2016-10 Impact factor: 4.806
Authors: Amnah Yamani; David Wu; Richard Ahrens; Lisa Waggoner; Taeko K Noah; Vicky Garcia-Hernandez; Catherine Ptaschinski; Charles A Parkos; Nicholas W Lukacs; Asma Nusrat; Simon P Hogan Journal: Mucosal Immunol Date: 2020-06-23 Impact factor: 7.313